Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 75.23-780.09136.79276.871,463.72

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 75.23 based on Mar2023 Standalone results.
Year Price to Cash Earnings (PCE)
Mar202375.23
Mar2022-780.09
Mar2021136.79
Mar2020276.87
Mar20191,463.72

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 75.23
Positive
Mar2022 -780.09
Negative
Mar2021 136.79
-50.59
Mar2020 276.87
-81.08
Mar2019 1463.72 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹122.4 Cr -3.5% 4.3% 16.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,920.7 Cr -0.9% 16.7% 79.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,317.5 Cr -0.4% -0.7% 20% Stock Analytics
KIRI INDUSTRIES ₹1,912.4 Cr -2.4% 16.2% 26.8% Stock Analytics
BODAL CHEMICALS ₹993.1 Cr -1.3% 2.6% 16.9% Stock Analytics
BHAGERIA INDUSTRIES ₹779.5 Cr -1.8% 20.5% 36.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.5%

4.3%

16.2%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses